It is noteworthy to compare the findings from these studies with the Australian and New Zealand College of Anaesthetists (ANZA) guidance indicating that discontinuing GLP-1 receptor agonists does not alter the risk of delayed gastric emptying that is inherently associated with diabetes [16,17,18,19,20,21,22,23,24,25,26]. This evidence concerns the gene GLP1R and diabetes mellitus.